CLINICAL_TRIALS trial_result · 2022-04-19

Clinical Trial Update: CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19 [Phase 2]

Phase 2 trial assessing safety and antiviral activity of brequinar in non-hospitalized COVID-19 patients completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Clear Creek Bio, Inc. | Conditions: COVID-19 Infection | Phase 2 | Status: COMPLETED | Results posted: 2022-04-19